Y. R. Van-gestel, I. Thomassen, V. E. Lemmens, J. F. Pruijt, M. P. Van-herk-sukel et al., Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.40, pp.963-969, 2014.

L. Vigan-o, N. Russolillo, A. Ferrero, G. De-rosa, E. Ferreri et al., Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study, Ann. Surg, vol.260, 2014.

I. Thomassen, Y. R. Van-gestel, V. E. Lemmens, and I. H. De-hingh, Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin, Dis. Colon Rectum, vol.56, pp.1373-1380, 2013.

D. Elias, E. Benizri, M. Pocard, M. Ducreux, V. Boige et al., Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.32, pp.632-636, 2006.

F. Cavaliere, M. D. Simone, S. Virzì, M. Deraco, C. R. Rossi et al., Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.37, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00663067

E. M. De-cuba, R. Kwakman, D. L. Knol, H. J. Bonjer, G. A. Meijer et al., Te Velde, Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies, Cancer Treat. Rev, vol.39, pp.321-327, 2013.

J. Phelip, O. Bouch-e, T. Conroy, P. Michel, C. Penna et al., Cancer colorectal M etastatique, 2014.

D. Elias, J. H. Lefevre, J. Chevalier, A. Brouquet, F. Marchal et al., Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.27, pp.681-685, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00378784

S. M. Strasberg, Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system, J. Hepatobiliary. Pancreat. Surg, vol.12, pp.351-355, 2005.

P. H. Sugarbaker, Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis, Semin. Surg. Oncol, vol.14, pp.254-261, 1998.

F. N. Gilly, P. Y. Carry, A. C. Sayag, A. Brachet, G. Panteix et al., Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis, Hepatogastroenterology, vol.41, pp.124-129, 1994.

D. Elias, M. Bonnay, J. M. Puizillou, S. Antoun, S. Demirdjian et al., Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. ESMO, vol.13, pp.267-272, 2002.

M. Narita, E. Oussoultzoglou, P. Fuchshuber, M. Chenard, E. Rosso et al., Prolonged portal triad clamping increases postoperative sepsis after major hepatectomy in patients with sinusoidal obstruction syndrome and/or steatohepatitis, World J. Surg, vol.36, pp.1848-1857, 2012.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann. Surg, vol.240, pp.205-213, 2004.

S. Balzan, J. Belghiti, O. Farges, S. Ogata, A. Sauvanet et al., The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy, Ann. Surg, vol.242, pp.824-828, 2005.

E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur. J. Cancer Oxf. Engl, issue.45, pp.228-247, 1990.

P. F. Innominato, S. Giacchetti, T. Moreau, R. Smaaland, C. Focan et al., Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963), Chronobiol. Int, vol.28, 2011.

R. V. Boccia, T. M. Cosgriff, D. L. Headley, S. Badarinath, and S. R. Dakhil, A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer, Clin. Colorectal Cancer, vol.9, pp.102-107, 2010.

K. Shitara, K. Matsuo, D. Takahari, T. Yokota, Y. Inaba et al., Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX, Eur. J. Cancer Oxf. Engl, issue.45, pp.1757-1763, 1990.

P. Pessaux, M. Chenard, P. Bachellier, and D. Jaeck, Consequences of chemotherapy on resection of colorectal liver metastases, J. Visc. Surg, vol.147, pp.193-201, 2010.

G. Morris-stiff, Y. Tan, and J. N. Vauthey, Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.34, pp.609-614, 2008.

F. G. Fernandez, J. Ritter, J. W. Goodwin, D. C. Linehan, W. G. Hawkins et al., Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases, J. Am. Coll. Surg, vol.200, pp.845-853, 2005.

O. Glehen, F. Kwiatkowski, P. H. Sugarbaker, D. Elias, E. A. Levine et al., Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.22, pp.3284-3292, 2004.

G. Passot, D. Vaudoyer, E. Cotte, B. You, S. Isaac et al., Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis, Ann. Surg, vol.256, pp.125-129, 2012.

C. D. Mann, M. S. Metcalfe, L. N. Leopardi, and G. J. Maddern, The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases, Arch. Surg. Chic. Ill, issue.139, pp.1168-1172, 1960.

M. Rees, P. P. Tekkis, F. K. Welsh, T. O'rourke, and T. G. John, Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients, Ann. Surg, vol.247, pp.125-135, 2008.

L. Aldrighetti, R. Castoldi, S. Di-palo, M. Arru, M. Stella et al., Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases, Chir. Ital, vol.57, pp.555-570, 2005.

D. Elias, M. Faron, D. Go-er-e, F. Dumont, C. Honor-e et al., A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases, Ann. Surg. Oncol, vol.21, 2014.

T. C. Chua, T. D. Yan, J. Zhao, and D. L. Morris, Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection, Eur. J. Surg

, Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.35, pp.1299-1305, 2009.

R. Kianmanesh, S. Scaringi, J. Sabate, B. Castel, N. Pons-kerjean et al., Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases, Ann. Surg, vol.245, pp.597-603, 2007.

O. Varban, E. A. Levine, J. H. Stewart, T. P. Mccoy, and P. Shen, Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases, Cancer, vol.115, pp.3427-3436, 2009.

F. Izzo, M. Piccirillo, R. Palaia, V. Albino, R. Di-giacomo et al., Management of colorectal liver metastases in patients with peritoneal carcinomatosis, J. Surg. Oncol, vol.100, pp.345-347, 2009.

B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag et al., Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial, Lancet Oncol, vol.14, issue.13, pp.70447-70456, 2013.

G. Glockzin, J. Rochon, D. Arnold, S. A. Lang, F. Klebl et al., A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial, BMC Cancer, vol.13, 2013.

G. Spolverato, A. Ejaz, N. Azad, and T. M. Pawlik, Surgery for colorectal liver metastases: the evolution of determining prognosis, World J. Gastrointest. Oncol, vol.5, pp.207-221, 2013.

R. Adam, G. Pascal, D. Castaing, D. Azoulay, V. Delvart et al., Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?, Ann. Surg, vol.240, pp.1052-1061, 2004.

B. Gruenberger, W. Scheithauer, R. Punzengruber, C. Zielinski, D. Tamandl et al., Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases, BMC Cancer, vol.8, 2008.